Supriya Lifescience IPO share allotment status date: How to check online; know GMP too

A day after the closing of the three-day initial public offering (IPO) of Supriya Lifescience Limited, a pharmaceutical ingredients supplier is trading at 47 percent premium in the grey market, IPO Watch data showed. Supriya Lifescience’s GMP value is commanding at ₹130 in the grey market today, IPO Watch data showed. Bids for 1,03,89,57,138 shares were received against 1,45,28,299 shares on offer in the initial share sale.

By the end of the day of public issue on Monday, the issue was subscribed 71.51 times due to the strong demand from investors. Retail investors offered 56 times the amount set out for them. The quota for non-institutional investors was subscribed 161 times, while the limit for qualified institutional investors was subscribed 31.8 times. The issue's price range was set at ₹265-274 per share. Ahead of its IPO, the company had raised ₹315 crore from key investors.

When can we expect allotment status?

The bidders who have subscribed to the public issue of Supriya Lifescience Limited, can expect the share allotment by this Thursday, that is December 23. If the allotment takes place on the expected date, then the shares will be credited to demat accounts of investors by December 27.

How to check Supriya Lifescience IPO share allotment status?

People who have subscribed to the Supriya Lifescience IPO can check the status online after the announcement on the website of Bombay Stock Exchange (BSE) through this link - https://www.bseindia.com/investors/appli_check.aspx. There go to the Equity under issue type option. Click on Equity under the issue type option and enter the issue name which is Supriya Lifescience IPO. Then, provide your Application number and PAN number. Tap on the search button and there you go! You will get your IPO status on your screens.

In addition to the BSE website, you can also check the allotment status at the website of Link Intime India Private Limited via this link - https://linkintime.co.in/MIPO/Ipoallotment.html.

Supriya Lifescience details

Supriya, which was founded in 2008, had 38 APIs as of October, with an emphasis on antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic, and anti-allergic segments. Between FY17 and FY21, it is the top exporter of chlorpheniramine maleate and ketamine hydrochloride, accounting for 45-50 percent and 60-65 percent of API shipments from India, respectively.